Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rony Kampalath"'
Publikováno v:
Journal of Radiology Nursing. 41:28-32
Autor:
Jonathan B. Yuval, Sujata Patil, Natalie Gangai, Dana M. Omer, Dmitriy G. Akselrod, Alice Fung, Carla B. Harmath, Rony Kampalath, Kyle Krehbiel, Sonia Lee, Peter S. Liu, John D. Millet, Ryan B. O’Malley, Andrei S. Purysko, Joseph C. Veniero, Ashish P. Wasnik, Julio Garcia-Aguilar, Marc J. Gollub
Publikováno v:
European Radiology.
Publikováno v:
Magnetic Resonance Imaging Clinics of North America. 29:389-403
Locoregional therapy (LRT) for hepatocellular carcinoma can be used alone or with other treatment modalities to reduce rates of progression, improve survival, or act as a bridge to cure. As the use of LRT expands, so too has the need for systems to e
Autor:
Darshan Gandhi, Matt Markese, Rony Kampalath, Matthew S. Davenport, Erin C Taylor, David T. Fetzer, Medine Böge, Sonia Lee, Mohamed Ebada, Asser Abou Elkassem, Kristen Bishop, Ghaneh Fananapazir, Emre Altinmakas, Stuart G. Silverman, Michael T. Corwin, Matthew D. F. McInnes, Erick M. Remer, Sarah Rosasco, Daniella Asch, Nicola Schieda, David E Sweet, Nicole E. Curci, Andrew D. Smith, Nayana U. Patel, Ayman H. Gaballah
Publikováno v:
American Journal of Roentgenology. 217:135-140
BACKGROUND. Incidental homogeneous renal masses are frequently encountered at portal venous phase CT. The American College of Radiology Incidental Findings Committee's white paper on renal masses r...
Autor:
Rony Kampalath, Neehar D. Parikh, Anum Aslam, Victoria Chernyak, William R. Masch, Kimberly A. Shampain
Publikováno v:
Abdominal Radiology. 46:3625-3633
Systemic therapy for the treatment of hepatocellular carcinoma (HCC) has rapidly evolved over the last 4 years; eight new drug regimens have gained Food and Drug Administration approval for treatment of advanced HCC since 2017. As several lines of th
Autor:
Sandeep Arora, Rony Kampalath, Anuradha S. Shenoy-Bhangle, Roopa Ram, Ania Z. Kielar, Mishal Mendiratta-Lala
Publikováno v:
Abdominal radiology (New York). 46(8)
The imaging findings after loco regional treatment of hepatocellular carcinoma are variable based on the type of treatment used, the timing interval of imaging after treatment, and the cross-sectional modality used for treatment response assessment.
Autor:
William R, Masch, Rony, Kampalath, Neehar, Parikh, Kimberly A, Shampain, Anum, Aslam, Victoria, Chernyak
Publikováno v:
Abdominal radiology (New York). 46(8)
Systemic therapy for the treatment of hepatocellular carcinoma (HCC) has rapidly evolved over the last 4 years; eight new drug regimens have gained Food and Drug Administration approval for treatment of advanced HCC since 2017. As several lines of th
Autor:
Marc D. Kohli, Edward J. Zaragoza, Rony Kampalath, Chantal Chahine, John Mongan, Michael Nguyentat, Justin Glavis-Bloom, Roozbeh Houshyar, Karen Tran-Harding, Paul Murphy, Thomas W. Loehfelm
Publikováno v:
Emergency radiology, vol 27, iss 6
Emergency Radiology
Emergency Radiology
Purpose The coronavirus disease 2019 (COVID-19) pandemic has led to significant disruptions in the healthcare system including surges of infected patients exceeding local capacity, closures of primary care offices, and delays of non-emergent medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b717ba630ded06415ada1b7588077522
https://escholarship.org/uc/item/32g647pf
https://escholarship.org/uc/item/32g647pf
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 38(7)
A better understanding of normal and abnormal US findings in the first trimester of pregnancy will help radiologists identify normal embryonic development, recognize the viability of an intrauterin...
Autor:
Shengri Liao, Bill C. Penney, Kristen Wroblewski, Hao Zhang, Cassie A. Simon, Rony Kampalath, Ming-Chi Shih, Naoko Shimada, Sheng Chen, Ravi Salgia, Daniel E. Appelbaum, Kenji Suzuki, Chin-Tu Chen, Yonglin Pu
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 39:27-38
The objective of this study was to assess the prognostic value of metabolic tumor burden on 2-deoxy-2-[(18)F]fluoro-D-glucose ((18)F-FDG) positron emission tomography (PET)/CT measured with metabolic tumor volume (MTV) and total lesion glycolysis (TL